this post was submitted on 16 Jun 2025
1 points (100.0% liked)

The Independent

33 readers
1 users here now

founded 4 months ago
MODERATORS
 

Shares of Sarepta Therapeutics have plunged again after the drugmaker reported a second death in connection with its gene therapy for muscular dystrophy

no comments (yet)
sorted by: hot top controversial new old
there doesn't seem to be anything here